Literature DB >> 27245456

SSPaQ: A Subtractive Segmentation Approach for the Exhaustive Parallel Quantification of the Extent of Protein Modification at Every Possible Site.

Guillaume Gabant1,2, Alain Boyer1, Martine Cadene3.   

Abstract

Protein modifications, whether chemically induced or post-translational (PTMs), play an essential role for the biological activity of proteins. Understanding biological processes and alterations thereof will rely on the quantification of these modifications on individual residues. Here we present SSPaQ, a subtractive method for the parallel quantification of the extent of modification at each possible site of a protein. The method combines uniform isotopic labeling and proteolysis with MS, followed by a segmentation approach, a powerful tool to refine the quantification of the degree of modification of a peptide to a segment containing a single modifiable amino acid. The strength of this strategy resides in: (1) quantification of all modifiable sites in a protein without prior knowledge of the type(s) of modified residues; (2) insensitivity to changes in the solubility and ionization efficiency of peptides upon modification; and (3) detection of missed cleavages caused by the modification for mitigation. The SSPaQ method was applied to quantify modifications resulting from the interaction of human phosphatidyl ethanolamine binding protein 1 (hPEBP1), a metastasis suppressor gene product, with locostatin, a covalent ligand and antimigratory compound with demonstrated activity towards hPEBP1. Locostatin is shown to react with several residues of the protein. SSPaQ can more generally be applied to induced modification in the context of drugs that covalently bind their target protein. With an alternate front-end protocol, it could also be applied to the quantification of protein PTMs, provided a removal tool is available for that PTM. Graphical Abstract ᅟ.

Entities:  

Keywords:  Covalent ligand; Mass spectrometry; PTM; Protein modification; Quantification

Year:  2016        PMID: 27245456     DOI: 10.1007/s13361-016-1416-y

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  30 in total

1.  Mass spectrometry of full-length integral membrane proteins to define functionally relevant structural features.

Authors:  Guillaume Gabant; Martine Cadene
Journal:  Methods       Date:  2008-10-29       Impact factor: 3.608

Review 2.  The resurgence of covalent drugs.

Authors:  Juswinder Singh; Russell C Petter; Thomas A Baillie; Adrian Whitty
Journal:  Nat Rev Drug Discov       Date:  2011-04       Impact factor: 84.694

3.  A chemical inhibitor reveals the role of Raf kinase inhibitor protein in cell migration.

Authors:  Shoutian Zhu; Kevin T Mc Henry; William S Lane; Gabriel Fenteany
Journal:  Chem Biol       Date:  2005-09

4.  Locostatin Disrupts Association of Raf Kinase Inhibitor Protein With Binding Proteins by Modifying a Conserved Histidine Residue in the Ligand-Binding Pocket.

Authors:  Anwar B Beshir; Christian E Argueta; Lochana C Menikarachchi; José A Gascón; Gabriel Fenteany
Journal:  For Immunopathol Dis Therap       Date:  2011

5.  Raf kinase inhibitor protein (RKIP) dimer formation controls its target switch from Raf1 to G protein-coupled receptor kinase (GRK) 2.

Authors:  Katharina Deiss; Caroline Kisker; Martin J Lohse; Kristina Lorenz
Journal:  J Biol Chem       Date:  2012-05-17       Impact factor: 5.157

6.  Epidemiology. Environment and disease risks.

Authors:  Stephen M Rappaport; Martyn T Smith
Journal:  Science       Date:  2010-10-22       Impact factor: 47.728

7.  Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation.

Authors:  K C Yeung; D W Rose; A S Dhillon; D Yaros; M Gustafsson; D Chatterjee; B McFerran; J Wyche; W Kolch; J M Sedivy
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

8.  Recognition and reactivity in the binding between Raf kinase inhibitor protein and its small-molecule inhibitor locostatin.

Authors:  Aleksandra N Rudnitskaya; Nicholas A Eddy; Gabriel Fenteany; José A Gascón
Journal:  J Phys Chem B       Date:  2012-08-15       Impact factor: 2.991

9.  Ligand binding study of human PEBP1/RKIP: interaction with nucleotides and Raf-1 peptides evidenced by NMR and mass spectrometry.

Authors:  Laurette Tavel; Lucie Jaquillard; Andreas I Karsisiotis; Fabienne Saab; Laurence Jouvensal; Alain Brans; Agnès F Delmas; Françoise Schoentgen; Martine Cadene; Christian Damblon
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

Review 10.  Status of large-scale analysis of post-translational modifications by mass spectrometry.

Authors:  Jesper V Olsen; Matthias Mann
Journal:  Mol Cell Proteomics       Date:  2013-11-01       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.